Pre-B cell acute lymphoblastic leukemia in the newborn

Area of Science:

• Pediatric Oncology
• Hematology
• Immunology

Background:

• Neonatal leukemia is a rare condition lacking comprehensive definition with modern techniques.
• Acute lymphoblastic leukemia (ALL) in newborns presents unique diagnostic and prognostic challenges.

Observation:

• Two infants diagnosed with acute lymphoblastic leukemia at birth and four weeks of age were analyzed.
• Detailed cytochemical, immunologic, and ultrastructural studies were performed on leukemic blasts.
• Immunologic cell marker studies revealed a pre-B cell phenotype in the lymphoblasts of both infants.

Findings:

• The leukemic cells in both neonates exhibited a pre-B cell immunophenotype.
• Both infants experienced relapses after significant clinical remission periods (17 and 44 weeks).
• One infant succumbed to the disease, while the other achieved a second remission.

Implications:

• The pre-B cell subtype of ALL, associated with poor prognosis in children, may also confer an unfavorable outlook in neonatal ALL.
• This study highlights the importance of immunophenotyping for understanding and managing congenital leukemia.
• Further research is warranted to confirm the prognostic significance of pre-B cell ALL in neonates.